VIEMED HEALTHCARE, INC. (VMD) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value (m); Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | (m) | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Deferred revenue · latest quarter (USD) | (m) | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | (m) | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 58.26M USD | Liabilities |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Amounts owed to suppliers | (m) | |
| Total deferred revenue | (m) | Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Deferred revenue due within one year | 8.00M USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | (m) | Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | (m) | |
| Deferred revenue included in other noncurrent obligations | (m) | Contract with Customer, Liability · Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- (m)
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Income taxes payable | $1.83M |
| Operating lease obligations | $4.51M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | (m) | (m) | (m) | $58.26M | (m) | $8.00M | (m) | (m) | (m) |
| 2026-03-31 | (m) | (m) | (m) | (m) | (m) | $51.56M | (m) | $7.48M | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | (m) | (m) | (m) | $55.63M | (m) | $7.52M | (m) | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | $66.86M | (m) | $7.81M | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | $42.98M | (m) | $7.19M | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | $41.33M | (m) | $6.79M | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | (m) | (m) | $43.77M | (m) | $6.69M | (m) | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | $42.73M | (m) | $6.82M | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | $42.77M | (m) | $6.72M | (m) | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | $38.60M | (m) | $6.09M | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $41.00M | (m) | $6.21M | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | (m) | (m) | $40.59M | (m) | $6.21M | $-6.21M | (m) | $-6.21M |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | $44.61M | (m) | $5.96M | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | $24.59M | (m) | $4.70M | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $19.95M | (m) | $4.62M | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | $25.51M | (m) | $4.64M | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | $22.68M | (m) | $4.40M | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | $22.96M | (m) | $3.89M | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $23.14M | (m) | $3.75M | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | $26.11M | (m) | $3.79M | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | $24.75M | (m) | $3.74M | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | $29.58M | (m) | $3.42M | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | $30.87M | (m) | $3.41M | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | $38.77M | (m) | $3.61M | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $41.05M | (m) | $3.28M | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $38.01M | (m) | $3.39M | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | (m) | $38.90M | (m) | $3.31M | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $36.30M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $31.60M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $24.83M | (m) | $2.79M | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $18.49M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | $18.85M | (m) | $2.48M | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | $16.76M | (m) | $2.27M | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | $15.92M | (m) | $2.00M | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |